I1 Imidazoline Receptor: Novel Potential Cytoprotective Target of TVP1022, the S-Enantiomer of Rasagiline

PLoS ONE - United States
doi 10.1371/journal.pone.0047890
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Novel I1-Imidazoline Agonist S43126 Augment Insulin Secretion in Min6 Cells

Journal of Diabetes & Metabolism
2012English

Combination of Ace Inhibitor With Agonist of I1 -Imidazoline Receptors: New Opportunities for Antihypertensive Therapy

Russian Journal of Cardiology
Cardiovascular MedicineCardiology
2016English

Chronic Ethanol Attenuates Centrally-Mediated Hypotension Elicited via Α2-Adrenergic, but Not I1-Imidazoline, Receptor Activation in Female Rats

Life Sciences
GeneticsMolecular BiologyPharmacologyBiochemistryMedicineToxicologyPharmaceutics
2009English

The Role of Rasagiline in the Treatment of Parkinson’s Disease

Clinical Interventions in Aging
MedicineGerontologyGeriatrics
2010English

Sorcin: A Novel Potential Target in Therapies of Cancers

Cancer Management and Research
Oncology
2019English

Characterization of the Hypothermic Effects of Imidazoline I2 Receptor Agonists in Rats

British Journal of Pharmacology
Pharmacology
2012English

Novel Class of Potential Therapeutics That Target Ricin Retrograde Translocation

Toxins
MutagenesisToxicologyHealth
2013English

SOX12: A Novel Potential Target for Acute Myeloid Leukaemia

British Journal of Haematology
Hematology
2016English

Single-Molecule Analysis of the Supramolecular Organization of the M2 Muscarinic Receptor and the Gα I1 Protein

Biophysical Journal
Biophysics
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy